Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-26-006133
Filing Date
2026-02-27
Accepted
2026-02-27 17:05:11
Documents
84
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tgtx20251231_10k.htm   iXBRL 10-K 2420677
2 EXHIBIT 10.25 ex_925369.htm EX-10.25 24062
3 EXHIBIT 10.26 ex_925370.htm EX-10.26 27151
4 EXHIBIT 21.1 ex_874096.htm EX-21.1 3779
5 EXHIBIT 23.1 ex_874097.htm EX-23.1 2774
6 EXHIBIT 31.1 ex_874098.htm EX-31.1 14036
7 EXHIBIT 31.2 ex_874099.htm EX-31.2 14455
8 EXHIBIT 32.1 ex_874100.htm EX-32.1 6341
9 EXHIBIT 32.2 ex_874101.htm EX-32.2 6989
15 a02.jpg GRAPHIC 48684
  Complete submission text file 0001437749-26-006133.txt   10096076

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA tgtx-20251231.xsd EX-101.SCH 70244
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tgtx-20251231_cal.xml EX-101.CAL 69405
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tgtx-20251231_def.xml EX-101.DEF 491113
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE tgtx-20251231_lab.xml EX-101.LAB 485496
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tgtx-20251231_pre.xml EX-101.PRE 537515
87 EXTRACTED XBRL INSTANCE DOCUMENT tgtx20251231_10k_htm.xml XML 1563723
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

EIN.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32639 | Film No.: 26701542
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)